Advertisement

Ads Placeholder
Loading...

ImExHS Limited

IME.AXASX
Healthcare
Medical - Healthcare Information Services
$0.39
$0.00(0.00%)
Australian Market is Open • 11:10

ImExHS Limited Fundamental Analysis

ImExHS Limited (IME.AX) shows moderate financial fundamentals with a PE ratio of -7.31, profit margin of -9.95%, and ROE of -19.01%. The company generates $0.0B in annual revenue with strong year-over-year growth of 35.08%.

Key Strengths

Cash Position15.65%
PEG Ratio-0.24
Current Ratio1.73

Areas of Concern

ROE-19.01%
Operating Margin0.23%
We analyze IME.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 21.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
21.8/100

We analyze IME.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

IME.AX struggles to generate sufficient returns from assets.

ROA > 10%
-12.15%

Valuation Score

Excellent

IME.AX trades at attractive valuation levels.

PE < 25
-7.31
PEG Ratio < 2
-0.24

Growth Score

Excellent

IME.AX delivers strong and consistent growth momentum.

Revenue Growth > 5%
35.08%
EPS Growth > 10%
41.60%

Financial Health Score

Excellent

IME.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
1.73

Profitability Score

Weak

IME.AX struggles to sustain strong margins.

ROE > 15%
-1901.35%
Net Margin ≥ 15%
-9.95%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IME.AX Expensive or Cheap?

P/E Ratio

IME.AX trades at -7.31 times earnings. This suggests potential undervaluation.

-7.31

PEG Ratio

When adjusting for growth, IME.AX's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values ImExHS Limited at 1.33 times its book value. This may indicate undervaluation.

1.33

EV/EBITDA

Enterprise value stands at 29.98 times EBITDA. This signals the market has high growth expectations.

29.98

How Well Does IME.AX Make Money?

Net Profit Margin

For every $100 in sales, ImExHS Limited keeps $-9.95 as profit after all expenses.

-9.95%

Operating Margin

Core operations generate 0.23 in profit for every $100 in revenue, before interest and taxes.

0.23%

ROE

Management delivers $-19.01 in profit for every $100 of shareholder equity.

-19.01%

ROA

ImExHS Limited generates $-12.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.15%

Following the Money - Real Cash Generation

Operating Cash Flow

ImExHS Limited generates limited operating cash flow of $564.71K, signaling weaker underlying cash strength.

$564.71K

Free Cash Flow

ImExHS Limited generates weak or negative free cash flow of $244.17K, restricting financial flexibility.

$244.17K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

IME.AX converts 1.16% of its market value into free cash.

1.16%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.19

vs 25 benchmark

ROA

Return on assets percentage

-0.12

vs 25 benchmark

ROCE

Return on capital employed

0.004

vs 25 benchmark

How IME.AX Stacks Against Its Sector Peers

MetricIME.AX ValueSector AveragePerformance
P/E Ratio-7.3128.54 Better (Cheaper)
ROE-19.01%738.00% Weak
Net Margin-9.95%-43982.00% (disorted) Weak
Debt/Equity0.040.34 Strong (Low Leverage)
Current Ratio1.732806.01 Neutral
ROA-12.15%-14624.00% (disorted) Weak

IME.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ImExHS Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

48.64%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

81.07%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

93.28%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ